Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/50098
Campo DC Valoridioma
dc.contributor.authorNaranjo, A.en_US
dc.contributor.authorOjeda-Bruno, S.en_US
dc.contributor.authorBilbao-Cantarero, A.en_US
dc.contributor.authorQuevedo-Abeledo, J. C.en_US
dc.contributor.authorDiaz-González, B. V.en_US
dc.contributor.authorRodríguez-Lozano, C.en_US
dc.contributor.otherNaranjo Hernandez, Antonio-
dc.date.accessioned2018-11-24T13:16:57Z-
dc.date.available2018-11-24T13:16:57Z-
dc.date.issued2015en_US
dc.identifier.issn0937-941Xen_US
dc.identifier.urihttp://hdl.handle.net/10553/50098-
dc.description.abstractA fracture liaison service in Spain is able to maintain 73 % of the patients on antiresorptive 2 years after the fracture.Introduction The purpose of this study was to evaluate the 2-year effectiveness of a program for the secondary prevention of fractures.Methods Fragility fractures in patients over 50 attending the emergency room in our centre are captured by the recruitment system of a secondary prevention program. The unit is attended by a nurse, coordinated by two rheumatologists and with the collaboration of primary care consisted of a training program and annual meetings. The outcome of the program was analysed 2 years after implementation, including: (1) percentage of attendees/eligible; (2) percentage of attendees who start treatment with antiresorptive; (3) percentage of patients who retain treatment after 6, 12, 18 and 24 months; and (4) factors associated to adherence.Results After 2 years of implementation, the program detected 1674 patients with fracture, of whom 759 finally entered the program (57 % of eligible). After 3 months, 82 % of patients prescribed an antiresorptive started treatment. After a year, 52 % of the patients in the program, 72 % of those of a prescribed treatment, were taking antiresorptives. Adherence at 24 months among those who had prescribed anti-fracture drugs was 73 %. Factors associated with adherence at 12 months were female sex (76 vs 45 %; p = 0.01) and previous treatment with antiresorptive (86 vs 68 %; p = 0.02).Conclusions In Spain, a program designed to prevent secondary fragility fractures based on the collaboration between primary care and rheumatology seems effective in terms of recruitment of patients and adherence to treatment in the mid/long-term.en_US
dc.languageengen_US
dc.relation.ispartofOsteoporosis Internationalen_US
dc.sourceOsteoporosis International[ISSN 0937-941X],v. 26 (11), p. 2579-2585en_US
dc.subject32 Ciencias médicasen_US
dc.subject.otherSecondary Preventionen_US
dc.subject.otherOsteoporotic Fracturesen_US
dc.subject.otherFragility Fracturesen_US
dc.subject.otherHip Fractureen_US
dc.subject.otherInitiationen_US
dc.subject.otherHospitalsen_US
dc.subject.otherProgramen_US
dc.subject.otherRisken_US
dc.subject.otherCareen_US
dc.titleTwo-year adherence to treatment and associated factors in a fracture liaison service in Spainen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1007/s00198-015-3185-zen_US
dc.identifier.scopus84944355498-
dc.identifier.isi000363042000004-
dcterms.isPartOfOsteoporosis International-
dcterms.sourceOsteoporosis International[ISSN 0937-941X],v. 26 (11), p. 2579-2585-
dc.contributor.authorscopusid7003297397-
dc.contributor.authorscopusid6602428868-
dc.contributor.authorscopusid7801311085-
dc.contributor.authorscopusid55295814500-
dc.contributor.authorscopusid56671406700-
dc.contributor.authorscopusid6603136298-
dc.description.lastpage2585en_US
dc.description.firstpage2579en_US
dc.relation.volume26en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000363042000004-
dc.contributor.daisngid32393321-
dc.contributor.daisngid550893-
dc.contributor.daisngid4801071-
dc.contributor.daisngid11153510-
dc.contributor.daisngid13419208-
dc.contributor.daisngid11274011-
dc.contributor.daisngid1048977-
dc.identifier.investigatorRIDE-7910-2010-
dc.description.numberofpages7en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Naranjo, A-
dc.contributor.wosstandardWOS:Ojeda-Bruno, S-
dc.contributor.wosstandardWOS:Bilbao-Cantarero, A-
dc.contributor.wosstandardWOS:Quevedo-Abeledo, JC-
dc.contributor.wosstandardWOS:Diaz-Gonzalez, BV-
dc.contributor.wosstandardWOS:Rodriguez-Lozano, C-
dc.date.coverdateNoviembre 2015en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.sjr1,48-
dc.description.jcr3,445-
dc.description.sjrqQ1-
dc.description.jcrqQ2-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Grupo de investigaciones infecciosas, nutricionales e inflamatorias en pacientes hospitalarios / Study Group on infectious, nutritional and inflammatory diseases in hospitalized patients-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Médicas y Quirúrgicas-
crisitem.author.orcid0000-0002-2013-6664-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameNaranjo Hernández, Antonio-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

27
actualizado el 24-mar-2024

Citas de WEB OF SCIENCETM
Citations

27
actualizado el 25-feb-2024

Visitas

31
actualizado el 11-nov-2023

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.